PIQ — Proteomics International Laboratories Share News
0.000.00%
Last trade - 00:00- AU$19.82m
- AU$16.40m
- AU$3.37m
Australia's Proteomics slips to four-month low on discounted share sale plan
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million
Brief: Proteomics International Laboratories Signs Agreement With Healius For Promarker Portfolio
Australia's Proteomics International soars on distribution deal with Healius
Australia's Proteomics climbs on US patent for endometriosis test
Brief: Proteomics International Labs Secures US Patent Grant For Endometriosis Innovative Diagnostic Test
Brief: Proteomics International Laboratories Says Restructure, Executive Appointment And Board Update
Brief: Proteomics International Laboratories Says Canadian Patent Secured For Promarkereso Diagnostic Test For Esophageal Adenocarcinoma
Appointment Of CEO And Managing Director
Brief: Proteomics International Laboratories Says US Patent Secured For Promarkereso Diagnostic Test
Proteomics at 9-month high on securing US patent for diagnostic test
Brief: Proteomics International Laboratories Receives A$2.2M In Research And Development Tax Incentive
Brief: Proteomics International Laboratories Says Richard Lipscombe To Retire As Managing Director
Australia's Proteomics jumps on $4 mln boost for Western Australia facility
Brief: Proteomics International Laboratories Says A$6 Million Expansion Of WA Proteomics Facility
Australia's Proteomics International slides on discounted placement
Brief: Proteomics International Laboratories Announces A$4.5 Mln Placement
Brief: Proteomics International Laboratories Seeks Trading Halt
Brief: Proteomics International Laboratories Says Patent Granted For Oxidx Oxidative Stress Test